(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, 99.0%, 1g

5-(2-tert-Butoxycarbonylamino-ethyl)-1-phenyl-1H-pyrazole-4-carboxylic acid methyl ester, 95.0%, 1g

N-(2-(2-(2-(2-(4-(6-Methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95%, 5mg

Solución de formaldehído, 1 l.

Methyl 5-methylpiperidine-3-carboxylate hydrochloride, 95.0%, 5g

3-Chlorophenol, 98.0%, 5g

4-Bromo-2-(bromomethyl)thiophene, 95+%, 1g

N-Phenyl isonicotinicamide, 95.0%, 10g

Temporizador de mesa

5-(aminocarbonyl)-1-methyl-1H-pyrazole-3-carboxylic acid, 1g

METHYL 2-AMINO-4-HYDROXY-5-METHOXYBENZOATE, 95.0%, 100mg

2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 98%, 1g

(S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione, 95.0%, 500mg